Novel 2h-indazoles As Ep2 Receptor Antagonists

Abstract

The present invention relates to novel 2H-indazoles of the general formula (I), methods for the preparation thereof and the use thereof for the production of pharmaceutical agents for the treatment of diseases and indications which are linked with the EP2- receptor.


Claims
IPC Classifications

Download Citation


Sign in to the Lens

Feedback